Cure8 trial brief
A long-term study that profiles immune cells, genes, diet, and the microbiome could help identify biomarkers that predict flares or response to therapy, which matters to people living with Crohn’s or ulcerative colitis.
Because it collects repeated imaging, biospecimens, and endoscopic assessments, it may generate insights into how disease activity changes over time and how treatments affect immune signatures.
Adults with Crohn’s disease or ulcerative colitis, relatives interested in genetic studies, clinicians and researchers focused on IBD immunology, biomarker discovery, and diet–microbiome interactions.
This ClinicalTrials.gov record describes a planned NIH observational natural-history study (not yet recruiting) to follow adults with Crohn’s disease, ulcerative colitis, or other IBD and some healthy relatives over time with deep immunophenotyping and multi-omic sampling.
Participants will have regular clinic visits every 6 months for at least 3 years with blood and stool collection, ultrasound, MRI, endoscopy (colonoscopy for all; upper endoscopy for some), tissue biopsies, questionnaires, and nutritional/dietary assessments.
The study aims to identify immune and genetic biomarkers, molecular signatures tied to disease activity and treatment response, and links between diet/nutrition and the microbiome. This is an observational, hypothesis-generating registry-style study collecting specimens and clinical data rather than testing a specific experimental treatment.
Enrollment is planned for about 100 participants and the record is marked NOT_YET_RECRUITING at a single site (NIDDK/NIH).
This is a registered observational trial (ClinicalTrials.gov NCT07619547) that is NOT_YET_RECRUITING and is designed to collect longitudinal data and biospecimens; it does not test a new therapy. Findings will be hypothesis-generating and will require independent validation. The extraction is from the trial record (partial extraction).
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Patients with IBD or new symptoms should understand that Crohn’s disease and ulcerative colitis can look very similar but affect different parts of the gut and may require different treatments. Accurate diagnosis matters...
The article explains how gut bacteria may contribute to IBD and summarizes common tests and treatments people are likely to encounter. It highlights emerging microbial therapies (probiotics and FMT) that some patients...
The study suggests vitamin D might help the immune system tolerate gut bacteria better and lower intestinal inflammation, which could mean fewer symptoms or flares for people with Crohn’s disease or ulcerative colitis.
